Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

MicroRNA-Based Drugs for Brain Tumors.

Anthiya S, Griveau A, Loussouarn C, Baril P, Garnett M, Issartel JP, Garcion E.

Trends Cancer. 2018 Mar;4(3):222-238. doi: 10.1016/j.trecan.2017.12.008. Epub 2018 Feb 9. Review.

PMID:
29506672
2.

Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma.

Séhédic D, Chourpa I, Tétaud C, Griveau A, Loussouarn C, Avril S, Legendre C, Lepareur N, Wion D, Hindré F, Davodeau F, Garcion E.

Theranostics. 2017 Oct 12;7(18):4517-4536. doi: 10.7150/thno.19403. eCollection 2017.

3.

Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.

Simonin K, N'Diaye M, Lheureux S, Loussouarn C, Dutoit S, Briand M, Giffard F, Brotin E, Blanc-Fournier C, Poulain L.

Apoptosis. 2013 Apr;18(4):492-508. doi: 10.1007/s10495-012-0799-x.

PMID:
23344663

Supplemental Content

Loading ...
Support Center